SiriusPoint (SPNT) AI Stock Analysis

• Market Cap: $2.38B
• Dividend Yield: N/A
• Average Volume (3M): 634.53K
• Price to Earnings (P/E): 5.5
• Beta (1Y): 0.33
• Revenue Growth: 7.87%
• EPS Growth: -4.68%
• Country: US
• Employees: 1,012
• Sector: Financial
• Sector Strength: 70
• Industry: Insurance - Reinsurance
• EPS (TTM): 0.70
• Shares Outstanding: 116,990,290
• 10 Day Avg. Volume: 640,440
• 30 Day Avg. Volume: 634,529
• PEG Ratio: 0.02
• Price to Book (P/B): 1.03
• Price to Sales (P/S): 0.80
• P/FCF Ratio: 4.96
• Enterprise Value/Market Cap: 0.91
• Enterprise Value/Revenue: 0.68
• Enterprise Value/Gross Profit: 1.72
• Enterprise Value/Ebitda: 3.44
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 1
• EPS Forecast (FY): 2.51
• Revenue Forecast (FY): $3.27B

• Rating: 71 Outperform
• Price Target: $22.50 ▲(10.51% Upside)
• Action: Reiterated Date: 03/16/26
• Date: Action: Reiterated 03/16/26

The score is driven primarily by improved 2025 financial performance (better growth, margins, ROE, and cash flow) and a positive earnings-call outlook with meaningful capital actions. These positives are tempered by historically volatile results/data-quality concerns in balance-sheet reporting and weaker near-term technical momentum. Low P/E supports the valuation component.

Positive Factors

Underwriting & top-line growth

SiriusPoint delivered sustained premium growth with core GWP up mid-teens and Insurance & Services expanding faster. A larger, diversified premium base (notably A&H growth) reduces cycle dependency and supports more predictable underwriting revenue and scale for distribution and retention over the next 2–6 months.

Capital strength and leverage reduction

Management’s active capital actions—preferred redemption, an announced buyback, and a BSCR well above regulatory targets—reduce expensive capital and leverage. Lower leverage and stronger regulatory capital enhance capacity to underwrite, deploy capital opportunistically, and sustain returns through industry cycles.

High-quality investment portfolio

A predominantly investment-grade, short-duration bond portfolio with yields above 4% supports stable investment income and liquidity. This asset mix helps match insurance liabilities, reduces credit risk, and provides durable yield support for underwriting margins amid market rate normalization.

Negative Factors

Balance-sheet data inconsistency

A material inconsistency in reported total assets undermines confidence in trend analysis and capital adequacy assessment. For a reinsurer, clarity on asset scale and reserving is critical to evaluate leverage, retro pricing and counterparty exposures; continued reporting ambiguity is a durable governance and analysis risk.

Pricing pressure in key classes

Significant rate declines in U.S. property catastrophe reinsurance compress underwriting margins where exposure is concentrated. Persistent market overcapacity or softening rates can erode profitability in those classes and limit the company’s ability to fully offset losses with higher pricing over a multi-quarter horizon.

Fee-income lumpiness & integration risk

Reliance on fee-based revenue that is uneven and M&A that is slow to accrete creates near-term earnings unpredictability. Integration of Assist America and World Nomads will take time to realize targeted fee/EBITDA contributions, challenging short-term cash conversion and the stability of non-underwriting income.

SiriusPoint Business Overview & Revenue Model

Company Description

SiriusPoint Ltd. provides multi-line insurance and reinsurance products and services worldwide. The company operates through two segments, Reinsurance, and Insurance & Services. The Reinsurance segment provides coverage to various product lines, which includes aviation and space, casualty, contingency, credit and bond, marine and energy, mortgage, and property to insurance and reinsurance companies, government entities, and other risk bearing vehicles. The Insurance & Services segment offers coverage to various product lines comprising accident and health, environmental, workers' compensation, and other lines of business, including a cross section of property and casualty lines. The company was formerly known as Third Point Reinsurance Ltd. and changed its name to SiriusPoint Ltd. in February 2021. SiriusPoint Ltd. was incorporated in 2011 and is headquartered in Pembroke, Bermuda.

How the Company Makes Money

SiriusPoint primarily makes money through (1) underwriting income and (2) investment income. Underwriting income is earned when the premiums the company collects for insurance and reinsurance coverage exceed its total costs to service that risk, including paid claims and loss adjustment expenses, changes in loss reserves for future claims, policy acquisition costs (such as commissions and underwriting/administrative expenses), and other operating expenses. The company writes both insurance and reinsurance: in insurance, it earns premiums directly from policyholders (or via distribution partners such as brokers and managing general agents, where applicable); in reinsurance, it earns premiums from ceding insurers in exchange for assuming a portion of those insurers’ risks under reinsurance contracts. Investment income is generated by investing the insurance “float” (premiums held before claims are paid) and the company’s capital, typically in a diversified portfolio of fixed income and other investments; returns from interest, dividends, and realized/unrealized gains and losses can materially affect overall earnings. Key factors influencing how much SiriusPoint earns include the pricing and terms it can obtain in specialty (re)insurance markets, loss experience (frequency and severity of claims, including catastrophe losses), reserve adequacy, expense discipline, and prevailing interest rates and credit conditions that impact portfolio yields and investment results. Specific significant partnerships contributing to earnings: null.

SiriusPoint Financial Statement Overview

Summary

2025 shows a strong profitability rebound (revenue +12.9%, net margin up to 14.3%) and improved ROE, supported by a sharp jump in operating/free cash flow ($514M). Offsetting this strength are clear signs of historical volatility (notably a major 2022 loss and uneven cash generation) and an inconsistency in the 2025 total assets figure that reduces confidence in balance-sheet trend quality.

Income Statement

Profitability and growth improved materially in 2025: revenue rose to $3.21B (+12.9%) and net margin expanded to 14.3% (from 7.6% in 2024), with operating profitability also stronger. Results are not perfectly stable across the cycle—2022 showed a sizable loss and negative margins—so earnings volatility remains a key risk for a reinsurer despite the recent momentum.

Balance Sheet

Leverage appears reasonable for the business, with debt-to-equity improving to 0.28 in 2025 (from 0.33 in 2024), and return on equity strengthening to 18.6%. The main concern is data inconsistency in total assets (2025 shows $121.2M vs ~$12–13B in prior years), which limits confidence in balance-sheet trend analysis and suggests reported scale may be misstated for that period.

Cash Flow

Cash generation strengthened significantly in 2025 with operating cash flow and free cash flow both at $514M (up sharply from $74.7M in 2024), and free cash flow roughly matching net income. However, cash flow has been volatile historically (e.g., very low in 2021 and 2024), and the provided operating cash flow coverage figure is low in 2025, pointing to potential variability in cash conversion.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	3.21B	2.61B	2.70B	2.17B	2.22B
Gross Profit	1.69B	728.40M	848.40M	121.30M	510.40M
EBITDA	622.50M	314.60M	393.90M	-376.00M	85.00M
Net Income	459.60M	199.90M	354.80M	-386.80M	58.10M
Balance Sheet
Total Assets	121.20M	12.52B	12.87B	11.04B	10.62B
Cash, Cash Equivalents and Short-Term Investments	902.40M	3.81B	3.69B	4.33B	2.08B
Total Debt	688.60M	639.10M	786.20M	778.00M	816.70M
Total Liabilities	7.51B	10.59B	10.34B	8.95B	8.12B
Stockholders Equity	2.47B	1.94B	2.51B	2.07B	2.50B
Cash Flow
Free Cash Flow	514.00M	74.70M	581.30M	292.50M	1.60M
Operating Cash Flow	514.00M	74.70M	581.30M	293.30M	1.60M
Investing Cash Flow	423.40M	343.60M	-332.20M	-1.30B	208.60M
Financing Cash Flow	-512.20M	-625.00M	-61.50M	-23.70M	24.30M

SiriusPoint Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 20.36
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SPNT, the sentiment is Negative. The current price of 20.36 is below the 20-day moving average (MA) of 20.95, below the 50-day MA of 20.56, and above the 200-day MA of 19.68, indicating a neutral trend. The MACD of -0.05 indicates Positive momentum. The RSI at 44.70 is Neutral, neither overbought nor oversold. The STOCH value of 26.49 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SPNT.

SiriusPoint Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HG	82 Outperform	$2.91B	4.91	22.09%	―	22.79%	-5.17%
RNR	80 Outperform	$12.79B	4.70	24.24%	0.57%	-3.96%	-48.08%
RGA	76 Outperform	$13.27B	11.38	9.48%	1.76%	2.10%	19.23%
SPNT	71 Outperform	$2.38B	5.55	20.87%	―	7.87%	-4.68%
GLRE	71 Outperform	$563.79M	6.59	11.10%	―	5.83%	-101.38%
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
OXBR	44 Neutral	$6.60M	-18.54	-50.32%	―	―	55.30%

SiriusPoint Corporate Events

SiriusPoint Unveils Global Restructuring and London Market Focus

On March 16, 2026, SiriusPoint Ltd. announced a restructuring that will see the specialty insurer and reinsurer operate through four core business areas: Global P&C Programs, Global Reinsurance, Global Accident & Health, and a new London Market Specialty division that encompasses its Lloyd’s platform. The move includes combining North America and International programs into a single Global P&C Programs unit under Patrick Charles and elevates the strategic importance of London by grouping casualty, energy, property, and marine leaders into the London Market Specialty division led by David Govrin, who also remains CEO of Global Reinsurance.

The company framed the changes as the next phase of its evolution following three years of improved underwriting, operating foundations, and business mix, supported by stronger financial performance at the end of 2025. As part of the reorganization, Rob Gibbs, President and CEO of SiriusPoint International, will depart following an orderly transition, while the Global Reinsurance and Global Accident & Health businesses remain unchanged, signaling continuity in key franchises amid a sharpened global structure aimed at capitalizing on growth opportunities and reinforcing SiriusPoint’s specialty positioning.

The most recent analyst rating on (SPNT) stock is a Buy with a $23.50 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.

SiriusPoint Posts Strong Q4 Results, Launches Buyback Plan

On February 18, 2026, SiriusPoint reported fourth-quarter 2025 net income of $240 million, or $1.97 per diluted share, with operating EPS of $0.70, an annualized ROE of 44.9% and operating ROE of 17.1%. The quarter saw 18% growth in gross and net written premiums, a core combined ratio of 92.9%, and a 9.9% rise in book value per diluted share ex-AOCI to $18.10, helped by reduced catastrophe losses despite softer prior-year reserve releases.

For full-year 2025, the company posted net income of $444 million and a 22.1% ROE, with operating EPS up 49% to $2.55, 16% gross written premium growth, a 91.7% core combined ratio, and a 23.6% increase in book value per diluted share ex-AOCI. Management highlighted ongoing improvement in underwriting quality and capital strength, announcing the redemption of Series B preference shares, which should lower leverage to about 23%, and a planned $100 million share repurchase program that underscores confidence in its balance sheet and future performance.

The most recent analyst rating on (SPNT) stock is a Hold with a $22.50 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.

SiriusPoint Expands Travel Insurance Platform With World Nomads Acquisition

On February 12, 2026, SiriusPoint’s subsidiary Sirius International UK Holdings II Ltd. agreed to acquire the World Nomads travel insurance business from Australian health insurer nib Group via a share and asset sale. World Nomads, with about $40 million in gross written premium, is a well-established global travel insurance and lifestyle brand that targets independent, lifestyle and adventure travelers, and offers products worldwide.

SiriusPoint announced that its subsidiary International Medical Group will assume World Nomads, a move that will significantly broaden IMG’s travel insurance distribution and extend its footprint into Australia, Brazil and Canada. The acquisition, together with IMG’s recent purchase of global travel assistance provider Assist America, is expected to create a more integrated global insurance and assistance platform, boosting IMG’s presence to 34 countries and enhancing scale and diversification.

Management highlighted that both the World Nomads and Assist America deals are expected to be accretive to return on equity and earnings per share, supporting SiriusPoint’s strategy of building a diversified, high-performing portfolio. The transaction was scheduled to close on the majority of the World Nomads group in the second or third quarter of 2026, with final completion anticipated in the second half of 2027, subject to regulatory approvals and other customary conditions, and is intended to deliver greater reach, enhanced services and long-term value for stakeholders.

The most recent analyst rating on (SPNT) stock is a Hold with a $22.50 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.

SiriusPoint Completes Strategic Divestment of Arcadian Stake

On January 30, 2026, a SiriusPoint Ltd. subsidiary completed the previously announced sale of its entire equity stake in Arcadian Holdings Limited, a Bermuda exempted company, to Comet Bidco Limited, an acquisition vehicle affiliated with Lee Equity Partners. Under the terms of the October 3, 2025 share purchase agreement, SiriusPoint’s Bermuda insurance unit received $140 million in cash consideration, subject to customary post-closing adjustments, with the deal closing after satisfaction of regulatory and other standard conditions, marking a strategic divestment that monetizes a non-core holding and potentially strengthens SiriusPoint’s capital position.

The most recent analyst rating on (SPNT) stock is a Buy with a $22.50 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.